Pulmonary Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (Beta-2 Agonists, Anti-cholinergic Agents, Oral and Inhaled Corticosteroids, Anti-leukotrienes, Antihistamines, Monoclonal Antibodies, Combination Drugs, Others), By Indication (Asthma, COPD (Chronic Obstructive Pulmonary Disease), Allergic Rhinitis, Pulmonary Arterial Hypertension, Cystic Fibrosis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), Countries and Companies Report
Pulmonary Drugs is projected to register a 6.9% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets